215 related articles for article (PubMed ID: 27397670)
1. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
[TBL] [Abstract][Full Text] [Related]
2. Independent highly sensitive characterization of asparagine deamidation and aspartic acid isomerization by sheathless CZE-ESI-MS/MS.
Gahoual R; Beck A; François YN; Leize-Wagner E
J Mass Spectrom; 2016 Feb; 51(2):150-8. PubMed ID: 26889931
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
[TBL] [Abstract][Full Text] [Related]
4. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
[TBL] [Abstract][Full Text] [Related]
5. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
Terashima I; Koga A; Nagai H
Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
[TBL] [Abstract][Full Text] [Related]
6. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
[TBL] [Abstract][Full Text] [Related]
7. A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies.
Furlong MT; Ouyang Z; Wu S; Tamura J; Olah T; Tymiak A; Jemal M
Biomed Chromatogr; 2012 Aug; 26(8):1024-32. PubMed ID: 22623136
[TBL] [Abstract][Full Text] [Related]
8. An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins.
Wang S; Kaltashov IA
Anal Chem; 2013 Jul; 85(13):6446-52. PubMed ID: 23713887
[TBL] [Abstract][Full Text] [Related]
9. A High-Throughput Bioluminescent Assay to Monitor the Deamidation of Asparagine and Isomerization of Aspartate Residues in Therapeutic Proteins and Antibodies.
Hsiao K; Alves J; Patel R; Adams M; Nashine V; Goueli S
J Pharm Sci; 2017 Jun; 106(6):1528-1537. PubMed ID: 28263844
[TBL] [Abstract][Full Text] [Related]
10. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
11. Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.
Kuang J; Tao Y; Song Y; Chemmalil L; Mussa N; Ding J; Li ZJ
Anal Bioanal Chem; 2021 Mar; 413(8):2113-2123. PubMed ID: 33543314
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
[TBL] [Abstract][Full Text] [Related]
13. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.
Wakankar AA; Borchardt RT
J Pharm Sci; 2006 Nov; 95(11):2321-36. PubMed ID: 16960822
[TBL] [Abstract][Full Text] [Related]
14. Site-specific rapid deamidation and isomerization in human lens αA-crystallin in vitro.
Takata T; Ha S; Koide T; Fujii N
Protein Sci; 2020 Apr; 29(4):955-965. PubMed ID: 31930615
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of deamidation and isomerization in β2-microglobulin by 18O labeling.
Fukuda M; Takao T
Anal Chem; 2012 Dec; 84(23):10388-94. PubMed ID: 23126476
[TBL] [Abstract][Full Text] [Related]
16. A quantitative LC-MS/MS method for comparative analysis of capture-antibody affinity toward protein antigens.
Lowenthal MS; Gasca-Aragon H; Schiel JE; Dodder NG; Bunk DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2726-32. PubMed ID: 21856254
[TBL] [Abstract][Full Text] [Related]
17. Deamidation and isomerization liability analysis of 131 clinical-stage antibodies.
Lu X; Nobrega RP; Lynaugh H; Jain T; Barlow K; Boland T; Sivasubramanian A; Vásquez M; Xu Y
MAbs; 2019 Jan; 11(1):45-57. PubMed ID: 30526254
[TBL] [Abstract][Full Text] [Related]
18. A conserved deamidation site at Asn 2 in the catalytic subunit of mammalian cAMP-dependent protein kinase detected by capillary LC-MS and tandem mass spectrometry.
Jedrzejewski PT; Girod A; Tholey A; König N; Thullner S; Kinzel V; Bossemeyer D
Protein Sci; 1998 Feb; 7(2):457-69. PubMed ID: 9521123
[TBL] [Abstract][Full Text] [Related]
19. Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit.
Zhou K; Cao X; Bautista J; Chen Z; Hershey N; Ludwig R; Tao L; Zeng M; Das TK
J Pharm Sci; 2020 Jan; 109(1):422-428. PubMed ID: 31469998
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
